Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, 60438 Frankfurt, Germany.
Department of Pharmacy, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
J Med Chem. 2022 Jul 28;65(14):9548-9563. doi: 10.1021/acs.jmedchem.2c00585. Epub 2022 Jul 7.
Nuclear receptor related 1 (Nurr1) is a transcription factor with neuroprotective and antineuroinflammatory properties. Observations from genetic studies and human patients support potential of Nurr1 as a therapeutic target in neurodegeneration, but due to a lack of high-quality chemical tools for pharmacological control of Nurr1, its target validation is pending. Nevertheless, considerable progress has recently been made in elucidating structural and functional characteristics of Nurr1, and several ligand scaffolds have been discovered. Here, we analyze Nurr1's structure and mechanisms compared to other nuclear receptors, summarize the known small molecule Nurr1 ligands, and discuss the available evidence for the therapeutic potential of Nurr1 in neurodegeneration.
核受体相关 1(Nurr1)是一种具有神经保护和抗神经炎症特性的转录因子。遗传研究和人类患者的观察结果支持 Nurr1 作为神经退行性变治疗靶点的潜力,但由于缺乏用于 Nurr1 药理学控制的高质量化学工具,其靶标验证仍有待进行。尽管如此,最近在阐明 Nurr1 的结构和功能特性方面取得了相当大的进展,并且已经发现了几种配体支架。在这里,我们分析了 Nurr1 的结构和机制与其他核受体的比较,总结了已知的小分子 Nurr1 配体,并讨论了 Nurr1 在神经退行性变中的治疗潜力的现有证据。